CORIXA CORP·4

Jul 14, 9:50 PM ET

CORIXA CORP 4

4 · CORIXA CORP · Filed Jul 14, 2005

Insider Transaction Report

Form 4
Period: 2005-07-12
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2005-07-12$4.40/sh57,515,477$253,068,0990 total
  • Purchase

    Series A Preferred Stock, par value $0.001 per share

    2005-07-12$517.65/sh12,500$6,470,6250 total
  • Purchase

    Series B Preferred Stock, par value $0.001 per share

    2005-07-12$172.01/sh37,500$6,450,3750 total
Footnotes (1)
  • [F1]All of the outstanding stock of Corixa Corporation was canceled in a merger of Corixa Corporation with GSK Delaware Corp., a wholly owned subsidiary of SmithKline Beecham Corporation, on July 12, 2005 pursuant to the Agreement and Plan of Merger, dated as of April 29, 2005, by and among SmithKline Beecham Corporation, GSK Delaware Corp. and Corixa Corporation.

Documents

1 file
  • 4
    bos10742_bos1gsk.xmlPrimary

    MAIN DOCUMENT DESCRIPTION